Sort
261,768 grants matching “gene therapy”
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$2,288,939Chi-Chao Chan · National Eye Institute · Z01 · FY2007 · EY
Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder
$2,288,766David G Amaral · University Of California At Davis · P50 · FY2018 · HD
NIDCD Core for Clinical Research and Care
$2,288,167Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2018 · DC
T Cell Costimulatory Pathways: Functions and Interactions
$2,287,759Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management
$2,287,391Michael S Gold · University Of Pittsburgh At Pittsburgh · UH3 · FY2021 · TR
T-Cell Receptor Gene Therapy for Human Cancers-Cures
$2,287,338Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,287,306Michael S Rafii · University Of Southern California · R33 · FY2023 · AG
A Massive Library of AAVs to Target Transcriptionally-Defined Primate Cell Types
$2,287,014William Richard Stauffer · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · MH
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER
$2,286,859University Of California San Francisco · P60 · FY2001 · HL
Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers
$2,286,821Paul M. Lieberman · Wistar Institute · P01 · FY2024 · CA
S.P.O.R.E. in Prostate Cancer
$2,286,693University Of Michigan At Ann Arbor · P50 · FY2004 · CA
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion
$2,286,537James C. Zimring · University Of Virginia · P01 · FY2024 · HL
Radiation and checkpoint blockade for cancer immune therapy
$2,286,184Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
$2,286,172Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Mayo Clinic Breast Cancer SPORE
$2,285,993Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2023 · CA
A defend and destroy approach to curing HIV
$2,285,732David T Scadden · Harvard University · U19 · FY2016 · HL
A defend and destroy approach to curing HIV
$2,285,732David T Scadden · Harvard University · U19 · FY2017 · HL
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-alpha1 in Neural and Cognitive Functions
$2,285,237Y. Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Cancer Center Support Grant
$2,284,983Mary C. Beckerle · University Of Utah · P30 · FY2017 · CA
Mechanisms of the BRCA-network in tumorigenesis and therapeutic response
$2,284,926Zhiyuan Shen · Rbhs -Cancer Institute Of New Jersey · P01 · FY2021 · CA
The role of ABI3 in Alzheimers disease
$2,284,811Jungsu Kim · Indiana University Indianapolis · RF1 · FY2021 · AG
Adaptations to Hypoxia
$2,284,489Kurt R Stenmark · University Of Colorado Denver · P01 · FY2007 · HL
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,284,358Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
DNA Sequencing and FACS Core Facilities
$2,284,339Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Clinical trials to prevent Alzheimer's Disease in Down Syndrome
$2,284,142Michael S Rafii · University Of Southern California · R33 · FY2024 · AG